Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Software (Cloud, On-Premise), By Service (Maintenance and Support, Consultation and Training, Implementation Service), By End-User (Hospitals, Long-term Care Facilities, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Market Overview

The global infection surveillance solutions market size was valued at USD 423.88 million in 2021. It is expected to reach USD 1363.28 million by 2030, growing at a CAGR of 13.86% during the forecast period (2022–2030). Factors such as Strong Government Policies and Increasing Number of Surgeries Worldwide, significantly drives the infection surveillance solutions market demand by 2030.

Infection surveillance solutions are used to evaluate preventive measures and identify infections. They are also required to assist in the diagnosis of bacteria that are resistant to antibiotics and infections brought on by unsterilized medical equipment. These solutions are highly advantageous for healthcare institutions, including precise employee health information, surgical databases, and real-time medical records. The demand for infection surveillance solutions is rising due to the high prevalence of hospital-acquired infections like urinary tract infections and surgical site infections. Due to their increased adoption rate for managing real-time pharmacy management and maintaining electronic healthcare records, hospitals have emerged as the top end-user.

Market Dynamics

Global infection surveillance solutions market drivers

Strong government policies

Clinicians face a challenge because hospital-acquired infections significantly cause mortality and morbidity. In order to assess the quality of the evidence and determine the strength of the recommendations, the GRADE system's grading of recommendations assessment, development, and evaluation (GRADE) principles are used. Each suggestion is grouped according to the available scientific evidence, theoretical justification, applicability, and economic impact. The national tool used for surveillance, prevention, and control of emerging infectious diseases is the CDC's Emerging Infections Programs (EIP). A network of state health departments, local health departments, academic institutions, other federal agencies, public health and clinical laboratories, infection preventionists, and healthcare organizations work together to form the EIP. The market expansion for infection surveillance solutions is driven by such regulatory frameworks, guidelines, and policy factors.

Increasing number of surgeries worldwide

The Lancet Commission for Global Surgery estimates that 11% of the global disease burden requires surgery, anesthesia, or both. This burden could be 30%, according to some studies. One hundred thousand people in LMICs would need 5000 surgeries to reduce the disease burden, according to LCoGS (low-to-middle-income countries). Low and middle-income surgical patients get infections 11% of the time. Wound infections affect 20% of African women who have cesarean sections, putting their health and capacity to care for their newborns at risk.

In the US, hospital infections cause patients to stay in the hospital for more than 400,000 extra days a year, costing an additional USD 10 billion (source: WHO). In Australia, health service providers are using these strategies to set up a new SSI surveillance program. Surgical Site Infection Improvement Programme combines process and outcome surveillance. Due to these factors, the market for infection surveillance is anticipated to grow during the forecast period.

Global infection surveillance solutions market restraints

Medical professionals' reticence to use cutting-edge medical tools

Professionals in the healthcare industry are frequently hesitant to adopt new technologies due in part to the scope and speed of change, the lack of education and training required, and concerns about liability and finance. Doctors have been hesitant to use e-health for a variety of reasons. The high cost of EHR systems, technical difficulties, disruptions to practices, and resistance to office change are a few of these reasons. HER may prompt surgeons to inquire about a patient's drug allergies as part of their medical history. In contrast, doctors are likelier to believe their patients would never make a mistake.

Global infection surveillance solutions market opportunities

Growth in emerging markets

Players in the infection surveillance solutions market are anticipated to have room to grow due to emerging economies like those in Latin America, Southeast Asia, Brazil, China, India, and others. India and China are home to most of the world's patients because they account for more than half of the global population. The market in these nations is expanding due to public pressure to raise the standard of hospital care, rising HAI costs to healthcare systems, the emergence of multi-drug-resistant microorganisms, and government initiatives.

Regional Analysis

By region, the global infection surveillance solutions market share is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North america dominates the global market

North America is the most significant shareholder in the global infection surveillance solutions market and is expected to grow at a CAGR of 12.45% during the forecast period. The infection surveillance market is probably driven by essential government initiatives and the rising incidence of HAIs in the United States. The National Action Plan (2020–2025) was introduced to combat bacteria resistant to antibiotics, such as methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae. The National Action Plan also has a section on boosting healthcare workers' coverage of influenza and pneumonia by eradicating HAIs. Additionally, institutions like the NIH are increasing the money they allocate to preventing prevalent HAIs like pneumonia and the flu. Therefore, infection surveillance solutions will help support this initiative.

Europe is expected to grow at a CAGR of 14.01%, generating USD 368.085 million during the forecast period. The European Centre for Disease Control and Prevention (ECDC) estimates that nearly 9 million healthcare-associated infections (HCAIs) affect patients in European hospitals yearly, or roughly one in 15 patients are at risk due to inadequate healthcare. Additionally, some hospitals assert that about 90,000 people in the European Union pass away annually. The IFR estimates that hospital-acquired infections cost the EU's healthcare system approximately EUR 7 billion annually. According to recent UK statistics, 6.4% of hospitalized patients will develop an infection acquired in the hospital (HAI). This is hugely upsetting for the patients, but estimates also indicate that the NHS spends close to GBP 1 billion annually on treating HAIs. Thus the need for infection surveillance solutions is anticipated to grow significantly during the forecast period.

In Asia-Pacific, China spends over CNY 6 trillion annually on healthcare. The National Center for Public Health Surveillance and Information Service hopes to modernize the medical sector using IT. IT support and service and health information resource management are its main functions. It manages China CDC's internal information construction and management and offers technical assistance for national disease control and prevention information systems. It develops, implements, uses, supervises, services, and shares big data and public health information. It works directly with affiliated institutions and guides Chinese CDCs by exchanging relevant scientific research and training. National Disease Reporting System includes China's provinces, prefectures, and counties (NDRS), and this system reports 35 infectious diseases. The province and county-level CDCs surveyed found that NDRS' core activities were adequate, but other support functions like information feedback, equipment, and financial support needed to be strengthened. It consists of monitoring systems for infectious diseases, occupational diseases, and food poisoning, as well as the Nationwide Disease Surveillance Points (DSPs), 145 reporting locations that cover 1% of China's population.

With increased healthcare-acquired infections, government initiatives, and awareness campaigns, the market for infection surveillance solutions is steadily expanding in Latin America. The World Health Organization estimates that over 450,000 healthcare-acquired infections (HAIs) occur in Mexico each year, endangering the well-being of patients and medical personnel. Patients who have undergone surgery in Mexico are increasingly becoming infected with Pseudomonas Aeruginosa, which is highly resistant to antibiotics. The Centers for Disease Control and Prevention (CDC) reported that, as of July 2020, it had received eight reports of infections, 6 of which involved patients who had undergone surgeries (cholecystectomy, plastic surgery, bariatric surgery, and cancer treatment) in Tijuana, Baja California, Mexico, and 2 of which involved patients who had undergone procedures in Jalisco, Mexico. Argentina received a USD 250 million loan in March 2021 to improve the public healthcare system, which provides services to 17 million people. The loan makes a robust public health system possible thanks to technology and innovation. The Argentinean government's efforts to convert healthcare into a digital industry stimulate the need for software like infection surveillance programs.

Promoting preventive care medicine through HAI management is a crucial issue for realizing Saudi Arabia's Vision 2030. The KSA government has set aside USD 1.5 billion for digital transformation and healthcare IT programs. Through these investments, a digital environment is created that encourages the use of software for various tasks, including infection surveillance. To safeguard patients and medical personnel, the South African government prioritized increasing infection prevention and control (IPC). The National Department of Health adopted the National IPC Strategic Framework and a guidebook for its implementation, both of which were produced with cooperation from WHO. Healthcare-associated infections are twice as common in low- and middle-income nations than in high-income countries, including South Africa. The 58 million South Africans living in poverty will benefit from the effective IPC measures. Such governmental initiatives are driving the infection surveillance solutions market growth.

Segmental Analysis

The global infection surveillance solutions market is segmented by software, service, and end-user.

Based on the software, the global infection surveillance solutions market is bifurcated into cloud and on-premise.

The on-premise segment is the highest contributor to the market and is expected to grow at a CAGR of 10.41% during the forecast period. Software with real-time surveillance for quicker logistics reports and quicker and simpler-based platforms are typically included in on-premises solutions for infection surveillance systems. These are widely used in hospitals and clinics worldwide and are particularly well-liked because they are more straightforward. Many of these programs also offer combined functionality, such as on-premise non-cloud and cloud utility in the cloud. Furthermore, most of this premises-based software is web-based.

For medical professionals looking to combat superbugs and other rapidly spreading infectious diseases, using rapid diagnostic platforms in conjunction with thorough electronic health records opens a new world of opportunities. Additionally, incorporating cloud-based bioinformatics solutions expands the possibilities for real-time patient monitoring, early disease diagnosis, patient surveillance solutions, and better ways to control the spread of infectious diseases while lowering the incidence of antibiotic resistance.

Based on service, the global infection surveillance solutions market is bifurcated into maintenance and support, consultation and training, and implementation service.

The maintenance and support segment owns the highest market share and is expected to grow at a CAGR of 15.83% during the forecast period. Patients expect a comfortable environment from a properly maintained and run facility. Facility professionals can take additional precautions by being aware of their surroundings and looking for common issues that could increase the risk of infection. Due to the factors above, businesses are providing surveillance and service systems emphasizing maintenance and support. Large government agencies frequently take the lead in establishing policies and regulations. For instance, the surgical site infection surveillance service is run by Public Health England's healthcare-associated infection and antimicrobial resistance department (HCAI & sr). This service aids hospitals in England in keeping track of incidents of infection following surgery and using the data to review or modify procedures as needed.

Brazil and Argentina decided to use World Bank loans to increase their surveillance capacity, and the United States Agency for International Development (USAID) redesigned its surveillance strategy to emphasize the use of data to enhance public health interventions (USAID 2005). Furthermore, the World Health Organization (WHO) member states must have key personnel and fundamental capacities in surveillance by the guidelines for implementing the draft revised International Health Regulations. These ongoing efforts result from surgical site infections (SSIs), a type of HAI that well-established techniques can prevent. With rates averaging 1-4% in high-income nations with clean operations, SSI rates are on the decline. But in low-income countries, the opposite is accurate, and there is currently a new wave of SSI implementation in these nations.

Based on the end-user, the global infection surveillance solutions market is bifurcated into hospitals and long-term care facilities.

The hospital segment is the highest contributor to the market and is expected to grow at a CAGR of 13.95% during the forecast period. Patients can contract healthcare-associated infections in hospitals, nursing homes, clinics, and health centers (HAIs). Infections increase mortality, hospital stays, morbidity, and healthcare costs. Some academic healthcare organizations focus on reducing infection risk in hospitals and other healthcare facilities because infection prevention and control are crucial to high-quality patient care. PraediAlert, an FDA-registered clinical surveillance system, helps hospitals improve patient care and safety by reducing hospital-acquired infections (HAI) and enhancing care team productivity and workflows to improve patient outcomes.

The emergence and spread of infections within a healthcare facility have been attributed to several factors in places like India, including inadequate monitoring mechanisms, skills, knowledge of prevalent and emerging diseases, laboratory capacity, excessive antibiotic use, and poor hygiene and sanitation. For instance, successfully implementing an infection prevention and control program in Indian healthcare settings is extremely difficult due to a lack of funding and staff, hospital overcrowding, and low nurse-to-patient ratios, even in intensive care units. Implementing or maintaining an infection control plan in a healthcare facility is difficult because many facilities do not have a focal person for infection prevention and control.

Recent Developments

• June 2021- The award-winning enterprise software platform of clinical surveillance company VigiLanz was used to launch a new audit solution. The new solution, VigiLanz Audit, complements VigiLanz's existing safety, quality, and risk products by streamlining, automating, and improving audit processes. VigiLanz Audit assists hospitals in quickly identifying emerging risks and ensuring ongoing quality improvements, in addition to saving time and resources.
• September 2022- A three-year commitment to invest in the growth of National Nursing Associations (NNAs) to support health equity and advance nursing education across 21 countries in Africa was announced by the BD Foundation, the charitable arm of the multinational medical technology company BD (Becton, Dickinson and Company).